Advanced Medical Solutions Group PLC
LSE:AMS

Watchlist Manager
Advanced Medical Solutions Group PLC Logo
Advanced Medical Solutions Group PLC
LSE:AMS
Watchlist
Price: 211 GBX -1.17%
Market Cap: 463.1m GBX

Advanced Medical Solutions Group PLC
Long-Term Debt

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Advanced Medical Solutions Group PLC
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Advanced Medical Solutions Group PLC
LSE:AMS
Long-Term Debt
ÂŁ69.7m
CAGR 3-Years
103%
CAGR 5-Years
52%
CAGR 10-Years
N/A
Abingdon Health PLC
LSE:ABDX
Long-Term Debt
ÂŁ767k
CAGR 3-Years
-9%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
ConvaTec Group PLC
LSE:CTEC
Long-Term Debt
$1.3B
CAGR 3-Years
1%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Tristel PLC
LSE:TSTL
Long-Term Debt
ÂŁ4.7m
CAGR 3-Years
-1%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Inspecs Group PLC
LSE:SPEC
Long-Term Debt
ÂŁ45m
CAGR 3-Years
-13%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Rua Life Sciences PLC
LSE:RUA
Long-Term Debt
ÂŁ639k
CAGR 3-Years
32%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Advanced Medical Solutions Group PLC
Glance View

Market Cap
462.6m GBX
Industry
Health Care

Advanced Medical Solutions Group Plc engages in the design, development, manufacture and distribution of wound care products, surgical dressings, medical grade materials, and medical adhesives and sutures for closing and sealing tissue. The company is headquartered in Winsford, Cheshire. The company went IPO on 2002-04-30. The firm operates through two business units for its sales, marketing and research and development (R&D) activities. Surgical business unit is focused on selling and marketing its branded products and are sold directly and through its distributors. Wound care business unit is focused on distribution and marketing its products that are supplied to medical device partners under its own brands. The Company’s products include ActivHeal, LiquiBand and RESORBA. Its technologies include collagen, cyanoacrylates, internal sealants, oxidized cellulose, sutures, alginates, foams, hydrocolloid and hydrogel.

AMS Intrinsic Value
310.53 GBX
Undervaluation 32%
Intrinsic Value
Price

See Also

What is Advanced Medical Solutions Group PLC's Long-Term Debt?
Long-Term Debt
69.7m GBP

Based on the financial report for Jun 30, 2025, Advanced Medical Solutions Group PLC's Long-Term Debt amounts to 69.7m GBP.

What is Advanced Medical Solutions Group PLC's Long-Term Debt growth rate?
Long-Term Debt CAGR 5Y
52%

Over the last year, the Long-Term Debt growth was -21%. The average annual Long-Term Debt growth rates for Advanced Medical Solutions Group PLC have been 103% over the past three years , 52% over the past five years .

Back to Top